NutraMedix Japanese knotweed contains Polygonum cuspidatum which has been used in Asian health practices for over 1,500 years. This potent botanical is rich in resveratrol, emodin, polydatin, and avonoids. These are powerful antioxidant plants used to defend against pathogenic microorganisms. Widely studied, these natural compounds have been shown to support microbial balance, immune regulation, as well as cardiovascular function and glucose metabolism. NutraMedix Japanese Knotweed is a professional strength 2oz liquid extract developed in direct response to practitioner requests for a high-quality, trusted formula for use in designing multi-layered patient protocols. It uses our proprietary, hydro-ethanol extraction process and quality-controlled, pharmaceutical-grade manufacturing to capture the root’s full bioactive compounds rather than just single constituents ensuring broad-spectrum with clinically trusted results.
Clinical studies show effectiveness by Japanese knotweed against tick-borne Borrelia (Lyme), co-infectants Babesia, and Bartonella, as well as against challenging bacterial and viral pathogens. Ingredient mechanisms of action: Japanese knotweed by Nutramedix contains Polygonum Cuspidatum and other polyphenolic compounds that act through multiple pathways, explaining its broad-spectrum clinical effects. Exhibits clinically studied activity against a range of microbes thereby supporting microbial balance. Enhances penetration of antimicrobial compounds into tissues by improving microcirculation and crossing the blood-brain barrier. Helps maintain normal levels of immune-modulating inflammatory markers. Scavenges free radicals, helping to protect cells from damage. Supports healthy enzyme activity, helping maintain healthy blood glucose balance and helps maintain healthy cholesterol.
Use 30 drops 1.5 mL in 4 oz. of water, twice daily, or as directed by a healthcare professional. Avoid breastfeeding. Consult a physician before use if taking anticoagulant or antiplatelet medications, estrogen therapy, or CYP-metabolized medications. Not for children under 3.
